Session » Measures & Measurement of Healthcare Quality Poster (0623–0659)

Date: Sunday, November 7, 2021

Time: 8:30AM-10:30AM

Meeting: ACR Convergence 2021

8:30AM-10:30AM: Abstract Number: 0656

A Survey Based Descriptive Study to Assess the Quality of Sleep in Rheumatic Patients

8:30AM-10:30AM: Abstract Number: 0658

ACCORD: A Novel Rheumatology Transition Clinic Structure for Adolescent and Young Adult Patients with Childhood Onset Rheumatic Disease

8:30AM-10:30AM: Abstract Number: 0647

Adherence to Hydroxychloroquine Dosing and Teleretinal Screening: Assessment and Quality Improvement

8:30AM-10:30AM: Abstract Number: 0653

Adherence to the 2015 ACR Guidelines for the Management of Polymyalgia Rheumatica and Screening for Osteoporosis at a Tertiary Care Medical Center

8:30AM-10:30AM: Abstract Number: 0652

Application of a GCA Probability Score to Patients Referred to a GCA Fast Track Clinic

8:30AM-10:30AM: Abstract Number: 0657

Assessing Patient Transition Outcomes from a Large Pediatric Rheumatology Center to Adult Healthcare

8:30AM-10:30AM: Abstract Number: 0654

Assessing Provider Knowledge and Opinions of the 2017 Guidelines for Perioperative Management of Antirheumatic Medications in a Single Academic Center

8:30AM-10:30AM: Abstract Number: 0637

Assessing the Rates of Cervical Cancer Screening in Women with Systemic Lupus Erythematosus and Rheumatoid Arthritis

8:30AM-10:30AM: Abstract Number: 0625

Brief Tailored Clinic Intervention (A-MATIC) Targets Nonadherence During SLE Visits: Two-year Sustainability and Outcomes

8:30AM-10:30AM: Abstract Number: 0636

Contraceptive and Pre-conception Counseling in an Academic Rheumatology Practice: A Needs Assessment to Identify Gaps in Care

8:30AM-10:30AM: Abstract Number: 0635

Correlation Between Provider Documentation and Patient Experience with Contraceptive Counseling in an Academic Rheumatology Practice

8:30AM-10:30AM: Abstract Number: 0634

Correlation Between the Functional Component of the Multidimensional Health Assessment Questionnaire (FN), Modified Health Assessment Questionnaire (MHAQ), Health Assessment Questionnaire II (HAQ-II) and a Single Functional Question (PF) in Patients with Rheumatic Disease

8:30AM-10:30AM: Abstract Number: 0646

Dark Adaptometry Screening for Hydroxychloroquine Retinopathy: A Pilot Study

8:30AM-10:30AM: Abstract Number: 0655

Depression and Fatigue: Two Forgotten Associated Comorbidities in Patients with Rheumatoid Arthritis

8:30AM-10:30AM: Abstract Number: 0651

Diagnostic Approach to Identifying Small Fiber Neuropathy in Patients with Sarcoidosis

8:30AM-10:30AM: Abstract Number: 0626

Does Higher Quality of Care in SLE Translate to Better Patient Outcomes?

8:30AM-10:30AM: Abstract Number: 0644

Follow-up Scheduling Appears Essential for Success of Rheumatology High Blood Pressure Protocol Across Health Systems

8:30AM-10:30AM: Abstract Number: 0628

Higher Quality of Care for Patients with Systemic Lupus Erythematosus in a Subspecialty Lupus Clinic: A Multi-Setting Cross-Sectional Study

8:30AM-10:30AM: Abstract Number: 0632

Impact of COVID-19 and Telehealth on RAPID3 Screening in an Academic Rheumatology Practice: Identifying Disparities in Care

8:30AM-10:30AM: Abstract Number: 0640

Implementation of Digital Prompt in Electronic Medical Records Improves Pneumonia Vaccination Rates in Patients Prescribed TNF-Inhibitors

8:30AM-10:30AM: Abstract Number: 0648

Improving Post-Rituximab Hypogammaglobulinemia Risk Assessments: A Fellows’ Quality Improvement Initiative

8:30AM-10:30AM: Abstract Number: 0639

Improving Pre-biologic Infection Screening Using a Best Practice Alert in Electronic Health Records

8:30AM-10:30AM: Abstract Number: 0638

Improving Safety in Rheumatology Patients by Closing Pre-screening Laboratory Care Gaps

8:30AM-10:30AM: Abstract Number: 0627

Increasing Rates of Standardized Depression Screening in Adolescents and Young Adults with Childhood-Onset Systemic Lupus Erythematosus in a Pediatric Rheumatology Clinic

8:30AM-10:30AM: Abstract Number: 0623

Intervention to Improve SLE Medication Adherence

8:30AM-10:30AM: Abstract Number: 0649

Optimizing SARS-CoV-2 Vaccine Timing in Rituximab-Treated Patients with Autoimmune Rheumatic Diseases: A Quality Improvement Intervention

8:30AM-10:30AM: Abstract Number: 0629

Patient and Physician Satisfaction with Telemedicine Utilization for Delivery of Care in Patients with SLE – A Single Centre Experience

8:30AM-10:30AM: Abstract Number: 0642

Prevalence and Risk Factors for Cardio-metabolic Abnormalities in Patients with Inflammatory Arthritis Attending Cardio-rheumatology Primary Prevention Clinics

8:30AM-10:30AM: Abstract Number: 0631

Provider Assessment of Telehealth Utility During COVID-19

8:30AM-10:30AM: Abstract Number: 0643

Tailored BP Connect Protocol with Implementation Support for Rheumatology Clinic Staff Exceeds Non-tailored Protocol at Improving Primary Care Referrals for Blood Pressure Follow-up

8:30AM-10:30AM: Abstract Number: 0630

Telemedicine in Rheumatology Care: A Systematic Review

8:30AM-10:30AM: Abstract Number: 0645

Time Burden of QTc Screening for HCQ Users at a Single VA Rheumatology Clinic

8:30AM-10:30AM: Abstract Number: 0641

Title: EHR-Supported Staff Protocol Improves Smoking Cessation in a Diverse Rheumatology Clinic: Updated Results of Quit Connect Dissemination

8:30AM-10:30AM: Abstract Number: 0659

Understanding the Rheumatologic Population We Serve Through Objective Analysis of Referrals and Diagnoses: Does Perception Match Actual Data?

8:30AM-10:30AM: Abstract Number: 0650

Use, Procurement Cost, and Adverse Events from IVIg Use in Rheumatic Disease

8:30AM-10:30AM: Abstract Number: 0624

Validation of a Self-reported Measure of Extent and Reasons for Nonadherence in SLE

8:30AM-10:30AM: Abstract Number: 0633

Value of the Routine Assessment of Patient Index Data 3 (RAPID3) as a Disease Activity Measure in Patients with Psoriatic Arthritis

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].